DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundation

Medication-overuse headache

Essential points for quick revision.

!
Escalate

Medication overuse does not explain thunderclap onset, fever or meningism, papilloedema, impaired consciousness, persistent neurological deficit or a major pregnancy-related change. Investigate those features urgently. Withdrawal of opioids, benzodiazepine-containing products or other dependence-forming medicines may require specialist supervision rather than an unsafe unsupported stop.

Synopsis

Identify headache made more frequent by regular acute-medicine exposure, explain the diagnosis without blame, and support withdrawal while treating the underlying primary headache disorder.

  • Suspect medication-overuse headache when headache is present on at least 15 days per month and one or more acute headache medicines have been overused for more than 3 months.
  • Triptans, opioids, ergots and combination analgesics reach the overuse threshold at 10 or more days monthly; paracetamol, aspirin and NSAIDs reach it at 15 or more days.
  • Count treatment days rather than tablet numbers, and include over-the-counter cold, pain and caffeine combinations that the patient may not regard as headache medicines.

Key red flags

Dependence complexity

Escalating strong opioid use, withdrawal between doses, multiple sedatives, severe mental illness or previous failed detoxification signals need for specialist support and sometimes inpatient care.

Investigation priorities

01
Eight-week headache and treatment diaryFirst step

Count total headache days, migraine-feature days and exposure days for every acute medicine class.

Management branches

IdentifyMake the hidden exposure visible

Headache has become frequent, chronic or progressively less responsive to rescue treatment.

  1. Ask for total monthly headache days and reconstruct every acute treatment day using prescriptions, purchased products and medicines taken for other pain.
  2. Apply the correct 10-day or 15-day class threshold over more than 3 months, considering cumulative exposure to several classes.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom